KDOQI To Update Diabetes Guideline

From: Renal Business Today


Draft of Updated Guideline Expected by January 2011
02/09/2010
NEW YORK—The National Kidney Foundation announced Feb. 9 plans to update its KDOQI Clinical Practice Guideline for Diabetes and Chronic Kidney Disease, which were first published in 2007.

“A revised diabetes and chronic kidney disease guideline will include recent studies focusing on the management of hyperglycemia such as the ACCORD (Action to Control Cardiovascular Risk in Diabetes) trial; we are aiming to complete the update process within a year, to ensure that practitioners and patients benefit from new knowledge as soon as possible,” said KDOQI Chair, Michael Rocco, MD of Wake Forest School of Medicine in North Carolina. “A draft is expected to be available for public review by January 2011.”

The work group is currently being assembled by Co-Chairs, Drs. Katherine Tuttle and Robert Nelson, who will return to their leadership positions.

“Our understanding of the diagnosis and management of diabetic kidney disease (DKD) is evolving rapidly and we want to ensure that the KDOQI guidelines reflect current knowledge. Moreover, findings from several recent trials suggest that certain drug treatment strategies widely believed to be beneficial for diabetic patients may in fact offer little benefit and may, in some settings, even be harmful,” said Tuttle, who is Medical and Scientific Director of Research at Providence Medical Research Center in Spokane, Wash.

“Emphasis on DKD prevention is reinforced by current evidence demonstrating long-term benefits of healthy lifestyle changes to reduce risk of type 2 diabetes, the root cause of most DKD,” said Nelson, who Staff Clinician at the National Institute of Diabetes and Digestive and Kidney Diseases. “By updating the guidelines to incorporate such new information, we seek to ensure that KDOQI remains an essential resource to clinicians in the management of their patients with and at risk for diabetic kidney disease.”

The KDOQI Evidence Review Team is currently assessing the literature before the work group begins writing. This process will be followed by a public review of the draft before its final publication next year.

“A thorough review of current literature inevitably identifies new questions that need to be addressed. Since investigators pay close attention to the research recommendations published with KDOQI guidelines, an update of these recommendations is fundamental to the guidelines update process. Guideline development and research data generation are iterative processes that should feedback to inform and update one another on an ongoing basis,” said Jeffrey Berns, MD of University of Pennsylvania School of Medicine and KDOQI’s Vice Chairs for guidelines.